Video

Elevating the Status of Pharmacists

Joe Moose, PharmD, explains how the Next-Generation Pharmacistâ„¢ awards elevate the status of pharmacists.

Joe Moose, PharmD, explains how the Next-Generation Pharmacist™ awards elevate the status of pharmacists.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Cardiovascular disease doctor or cardiologist holding red heart in clinic or hospital exam room office for csr professional medical service, cardiology health care and world heart health day concept - Image credit: Chinnapong | stock.adobe.com
Image credit: AwieDarwis | stock.adobe.com
Image credit: viperagp | stock.adobe.com
Image credit: kitsawet | stock.adobe.com
Inflammation concept, inflammated human tissues 3d rendering - Image credit: picture-waterfall | stock.adobe.com
Related Content
Guiding Patients Through Allergy Medication Safety: Pharmacists’ Role Following FDA Warning on Cetirizine and Levocetirizine
July 8th 2025

Guiding Patients Through Allergy Medication Safety: Pharmacists’ Role Following FDA Warning on Cetirizine and Levocetirizine

Dina Ibrahim, PharmD Candidate 2026
Pharmacy Focus: Navigating Seasonal Allergies
May 28th 2025

Pharmacy Focus: Navigating Seasonal Allergies

Luke Halpern, Assistant Editor Derek Webb, PharmD
Stethoscope surrounded by crowd figurines | Image Credit: © Eti - stock.adobe.com
July 7th 2025

How Cuts to Federal Health Agencies Fuel Chronic and Infectious Disease Crises

Alexandra Gerlach, Associate Editor
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
When Less Is More: Addressing Polypharmacy in High-Risk Populations
July 7th 2025

When Less Is More: Addressing Polypharmacy in High-Risk Populations

Andrew E. Esch, MD, MBA Alana Hippensteele, Lead Editor
Coronary artery plaque
July 4th 2025

Elevated Remnant Cholesterol, Lp-PLA2 Linked to Heightened Risk of Composite Adverse Events

Luke Halpern, Assistant Editor